Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting
Suboptimal statin utilization (53.8%) for primary CVD prevention in type 2 diabetes was observed, with utilization heavily influenced by comorbidities. Urgent quality improvement initiatives are needed to ensure statin access aligns with guideline recommendations for patients with hypertension, dyslipidemia, and poor glycemic control in the study area.
Authors
- Arega D. Alene (ORCID: https://orcid.org/0000-0002-2491-4603)
- Koricho Simie Tolla (ORCID: https://orcid.org/0009-0006-1825-4502)
- Hassen Ahmed Yesuf (ORCID: https://orcid.org/0000-0003-4973-2432)
- Zeru Seyoum Wendimagegn (ORCID: https://orcid.org/0009-0002-4879-3161)
- Wubshet Abraham Alemu (ORCID: https://orcid.org/0009-0005-0134-8935)
- Feyisa Assefa Dhaba
- Firaol Lamessa Kitila
- Kedir Ali Getahun
- Surafel Mekasha Woldeyes
Institutions
- Asossa University (ET)
- Woldia University (ET)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-07-04
- DOI
- https://doi.org/10.3389/fendo.2025.1472300
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01